OakChart

PACS Group Inc

PACSHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

50.06+0.96 (1.96%)
2026-11-11 23:26 CET
Market cap
7,793.35 USD m
Revenue, TTM
5,705.05 USD m
Net income, TTM
277.58 USD m
Free cash flow, TTM
447.73 USD m
EPS diluted, TTM
1.72
P/E
29.08
Compare

Price

PACS against its 20, 50 and 200-day averages
2050200beatmiss
30.0040.0050.001.8M3.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PACSclose 50.0620-day 48.1850-day 45.02200-day 40.2250.0652w high

3.1% under the 52-week high of 51.68 on 4 Nov 2026. 52-week low 10.31 on 14 Nov 2025. Last 15 sessions, 13.9% high to low

Volume 1.27× normal · the line is the 50-bar volume average

Profile

PACS
52-week range, 96% of the way up
10.3151.68

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Salt Lake City, UT.

IndexRUT
Employees47455
IPOApr 11, 2024
Beta-0.11
ATR, 14d2.07
Rel volume1.27
Short float9.41%
Insider own71.26%
Inst own31.43%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap7.95B
Enterprise Value11.26B
Income277.58M
Sales5.71B
Book/sh7.65
Cash/sh0.81
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees47455
IPOApr 11, 2024

Ratios

P/E29.08
Forward P/E18.25
PEG0.98
P/S1.39
P/B6.54
P/C61.98
P/FCF17.75
EV/EBITDA22.41
EV/Sales1.97
Quick Ratio0.80
Current Ratio0.80
Debt/Eq2.83
LT Debt/Eq2.66
Option/ShortYes / Yes

Earnings

EPS (ttm)1.72
EPS next Y2.74
EPS next Q0.63
EPS this Y31.74%
EPS next Y12.95%
EPS next 5Y18.67%
EPS past 3/5Y-41.50% -10.97%
Sales past 3/5Y29.74% 45.92%
EPS Y/Y TTM62.56%
Sales Y/Y TTM11.02%
EPS Q/Q16.59%
Sales Q/Q11.45%
EarningsNov 03 AMC
EPS/Sales Surpr.8.81% 2.69%

Ownership

Insider Own71.26%
Insider Trans-2.28%
Inst Own31.43%
Inst Trans4.28%
ROA4.81%
ROE26.62%
ROIC6.24%
Gross Margin15.82%
Oper. Margin7.52%
Profit Margin4.87%
SMA203.91%
SMA5011.19%
SMA20024.47%
Trades-

Technical

Shs Outstand158.72M
Shs Float45.62M
Short Float9.41%
Short Ratio5.45
Short Interest4.29M
52W High51.68 -3.13%
52W Low10.31 385.55%
Volatility5.55% 4.41%
ATR (14)2.07
RSI (14)60.49
Beta-0.11
Rel Volume1.27
Avg Volume787.17K
Volume1,000,221

Performance

Perf Week-0.40%
Perf Month12.80%
Perf Quarter11.27%
Perf Half Y21.21%
Perf YTD30.40%
Perf Year306.66%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price61.33
Prev Close49.10
Price50.06
Change %1.96%

Analyst ratings

latest 10 of 12
DateActionAnalystRating changeTargetImplied
Dec 17, 2025ResumedJJP MorganOverweight$44-12.1%
Dec 17, 2024DowngradeJJP MorganOverweight → Neutral$18-64.0%
Nov 06, 2024ResumedJJP MorganOverweight$40-20.1%
Oct 09, 2024InitiatedUUBSBuy$50-0.1%
Sep 11, 2024ResumedCCitigroupBuy$45-10.1%
Jun 28, 2024InitiatedMMacquarieOutperform$35-30.1%
May 06, 2024InitiatedTTruistBuy$32-36.1%
May 06, 2024InitiatedSStephensOverweight$31-38.1%
May 06, 2024InitiatedRRBC Capital MktsOutperform$30-40.1%
May 06, 2024InitiatedOOppenheimerOutperform$31-38.1%

Peers

Mkt cap
TickerCompanyMkt cap
ENSGEnsign Group Inc10.86B
NHCNational Healthcare Corp3.30B
EHCEncompass Health Corp13.96B
PNTGPennant Group Inc1.29B
BKDBrookdale Senior Living Inc2.21B
ADUSAddus HomeCare Corp2.34B
GRDNGuardian Pharmacy Services Inc3.17B
HCSGHealthcare Services Group Inc1.70B
SNDASonida Senior Living Inc1.67B
OHIOmega Healthcare Investors Inc14.64B

Insider trading

latest 14 of 96
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Murray Jason HulseCo-Founder, CEO & ChairmanNov 05 '26Sale50.6419,235974,02753,934,866Nov 09 06:03 PM
John MitchellOfficerNov 06 '26Proposed Sale50.20336,31216,882,862Nov 06 05:54 PM
Lewis Michelle ReneeChief Accounting OfficerNov 04 '26Sale50.063,172158,776340,338Nov 04 06:01 PM
Murray Jason HulseCo-Founder, CEO & ChairmanNov 04 '26Sale50.24167,4348,412,40253,954,101Nov 04 06:01 PM
Murray Jason HulseCo-Founder, CEO & ChairmanNov 02 '26Sale46.0231,3581,443,01054,148,039Nov 04 06:01 PM
Murray Jason HulseCo-Founder, CEO & ChairmanNov 03 '26Sale46.5026,5041,232,34854,121,535Nov 04 06:01 PM
Hancock MarkDirectorNov 04 '26Sale50.45186,6969,418,39053,318,884Nov 04 06:00 PM
Hancock MarkOfficerNov 04 '26Proposed Sale50.45186,6969,418,384Nov 04 05:49 PM
Lewis Michelle ReneeChief Accounting OfficerOct 28 '26Sale50.129,464474,365345,874Oct 30 07:01 PM
Lewis Michelle ReneeChief Accounting OfficerOct 29 '26Sale50.042,364118,283343,510Oct 30 07:01 PM
Murray Jason HulseCo-Founder, CEO & ChairmanOct 28 '26Sale50.106,899345,62454,181,301Oct 30 07:01 PM
Murray Jason HulseCo-Founder, CEO & ChairmanOct 29 '26Sale50.051,90495,28954,179,397Oct 30 07:01 PM
Hancock MarkDirectorOct 28 '26Sale50.109,024452,12053,509,860Oct 30 07:00 PM
Hancock MarkDirectorOct 29 '26Sale50.024,280214,10153,505,580Oct 30 07:00 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 200
  • Fifty-Eight PACS Post-Acute Locations Named Top Nursing Homes for 2027 by U.S. News & World Report (Business Wire)
  • PACS Beats And Raises Again, But Florida-Scale M&A And A Wider GAAP Gap Complicate The Upgrade (Earnings Whispers) +7.67%
  • PACS Group, Inc. Reports Third Quarter 2026 Results (Business Wire)
  • Omega Reports Third Quarter 2026 Results and Recent Developments (Business Wire)
  • PACS Faces A Higher Bar As Aduro Deal And Third Guidance Raise Hopes Collide (Earnings Whispers)
  • PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Call (Business Wire)
  • Omega to Transition Operations of 32 Facilities in Florida to PACS Group (Business Wire)
  • Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine (Business Wire)
  • Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
  • PACS Group Announces Chief Legal Officer Transition (Business Wire)
  • PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026 (Business Wire)
  • PACS Group Shares Rise 3.3% as Company Plans Florida Expansion and Completes More Eduro Acquisitions (InvestorsHub)
  • PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities (Business Wire)
  • PACS Group Inc (PACS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.6300.5790.3701,4991,4596
2026Q22026-08-040.6300.5370.4721,4281,4146
2026Q12026-05-110.6260.4000.4981,4201,3646
2025Q42026-02-260.5380.4640.3811,3601,3835
2025Q32025-11-190.3200.4500.3181,3451,1111
2025Q22025-08-180.4500.3890.3081,1071,1343
2025Q12025-05-190.3660.4240.1711,1001,0902
2024Q42025-02-260.3910.3960.2401,0441,0554
2024Q32024-11-080.3480.3430.101998.81991.785
2024Q22024-08-120.5600.353-0.072981.85919.227
2024Q12024-05-130.3800.2920.322934.72883.385
2026Q4--0.626--1,6156
2027Q1--0.660--1,7553
2027Q2--0.677--1,7853
2027Q3--0.677--1,7933
2027Q4--0.703--1,8133

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY0.922-4.5803,111-
2024FY1.6341.4830.3593,9543,971
2025FY1.8441.7391.2205,2905,314
2026FY-2.429--5,950
2027FY-2.743--6,842
2028FY-3.081--7,508

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-066501,6151,4811,702
2026Q4S2026-11-046401,5831,4811,677
2026Q4S2026-11-036301,5431,4811,637
2026Q4S2026-10-206301,5441,4811,637
2026Q4S2026-10-196401,5441,4811,637
2026Q4S2026-10-096601,5441,4811,637
2026Q4S2026-10-056501,5381,4811,637
2026Q4S2026-09-206411,5231,4811,597
2026Q4S2026-09-176511,5231,4811,597
2026Q4S2026-09-036511,5221,4811,597
2026Q4S2026-08-266411,5171,4461,597
2026Q4S2026-08-066421,5171,4461,597
2026Q4S2026-08-056321,5071,4461,597
2026Q4S2026-07-266211,4951,4461,598

Estimate history

EPS, annual1.9466.1074.580.3591.2221.7216
Period20212022202320242025TTM
EPS, quarterly0.1010.240.1710.3080.3180.3810.4980.4720.371
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1166.5632421.9943111.4924089.7345288.9325705.05
Period20212022202320242025TTM
Sales, quarterly1026.3051207.8881277.151309.2361344.5671357.9791420.4941427.9981498.578
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual-24.64324.643155.178156.615158.723
Period20212022202320242025MRQ
Shares, quarterly155.178155.178155.178156.57156.615156.615157.165158.336158.723
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue5,705.055,288.934,089.733,111.492,421.991,166.56
Cost of Goods Sold Incl. D&A4,802.754,564.273,622.852,690.062,043.63986.37
Gross Profit902.30724.66466.88421.44378.37180.19
Selling, General and Administrative Excl. Other473.44414.76341.30169.94149.0196.83
Other Operating Expense0.000.000.000.000.000.00
Operating Income428.86309.90125.58251.50229.3683.36
Interest Expense26.1428.3644.3449.9225.545.28
Unusual Expense0.710.31-4.3943.730.000.00
Net Income Before Taxes397.70284.45101.55157.32207.0481.43
Income Taxes120.0892.9946.2144.4456.5533.48
Consolidated Net Income277.61191.4655.34112.88150.5047.95
Net Income From Continuing Operations277.58191.5455.76112.87150.5047.95
Net Income277.58191.5455.76112.87150.5047.95
EPS (Recurring)1.701.220.345.826.111.95
EPS (Basic, Before Extraordinaries)1.761.230.364.586.111.95
EPS (Diluted)1.721.220.364.586.111.95
EBITDA502.52365.57166.39277.13251.6790.51
Non-Operating Income (Expense)-4.303.2215.93-0.543.223.35
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense84.7342.7191.28---
Price To Earnings Ratio28.5228.52----
Price To Sales Ratio1.191.140.50---
Gross Margin15.8213.7011.4213.5415.6215.45
Operating Margin7.525.863.078.089.477.15
Net Margin4.873.621.363.636.214.11
Shares Outstanding158.72156.62155.1824.6424.64-
Market Capitalization7,793.357,793.352,034.381,987.83--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,498.581,428.001,420.491,357.981,344.571,309.241,277.151,207.89
Cost of Goods Sold Incl. D&A1,260.451,204.361,188.141,149.801,155.771,128.401,130.291,046.27
Gross Profit238.13223.64232.35208.18188.80180.83146.86161.62
Selling, General and Administrative Excl. Other134.06113.57112.31113.49102.43100.2698.5888.67
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income104.07110.06120.0394.6986.3780.5748.2872.95
Interest Expense5.106.046.428.588.534.356.909.30
Unusual Expense4.351.78-5.410.000.100.070.142.12
Net Income Before Taxes91.31105.84113.7486.8176.3078.6142.7361.20
Income Taxes30.5029.4933.0727.0323.9727.6514.3525.01
Consolidated Net Income60.8176.3580.6759.7852.3350.9728.3836.19
Net Income From Continuing Operations60.8276.3780.6959.7052.4150.9628.4737.20
Net Income60.8276.3780.6959.7052.4150.9628.4737.20
EPS (Recurring)0.390.480.470.380.320.310.170.25
EPS (Basic, Before Extraordinaries)0.380.480.510.380.330.330.180.24
EPS (Diluted)0.370.470.500.380.320.310.170.24
EBITDA124.15130.19138.11110.07100.7793.7560.9885.86
Non-Operating Income (Expense)-3.313.59-5.290.70-1.442.471.49-0.33
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense35.8020.4116.0712.449.8910.759.649.72
Price To Earnings Ratio28.5228.3327.2637.02----
Price To Sales Ratio1.191.240.961.140.440.440.420.49
Gross Margin15.8915.6616.3615.3314.0413.8111.5013.38
Operating Margin6.947.718.456.976.426.153.786.04
Net Margin4.065.355.684.403.903.892.233.08
Shares Outstanding158.72158.34157.17156.62156.62156.57155.18155.18
Market Capitalization7,793.356,748.725,048.146,012.452,130.592,004.901,744.202,034.38

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments232.05160.8478.3966.12-
Short Term Receivables702.09716.52600.07420.12-
Inventories0.000.000.000.00-
Other Current Assets135.5960.9043.6924.92-
Total Current Assets1,069.74938.26722.15511.16-
Net Property, Plant & Equipment4,169.273,985.102,585.341,775.61-
Total Investments and Advances105.6091.3855.9648.31-
Intangible Assets68.0667.0665.2961.49-
Deferred Tax Assets938.04924.19---
Other Assets107.40114.8884.0065.32-
Total Assets6,458.116,120.873,512.742,461.89-
Short Term Debt Incl. Current Port. of LT Debt186.46314.26127.20182.43-
Accounts Payable192.23175.06140.95110.58-
Other Current Liabilities622.73489.11188.78190.86-
Total Current Liabilities1,001.43978.43456.93483.86-
Long Term Debt3,411.623,312.232,718.471,743.12-
Provision for Risks Charges192.56164.986.7415.29-
Deferred Tax Liabilities874.08877.96---
Other Liabilities25.9871.58228.88150.97-
Total Liabilities5,505.665,405.183,411.012,393.24-
Non-Equity Reserves0.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.00-
Common Equity946.77709.5596.1363.65-
Total Shareholders Equity946.77709.5596.1363.65-
Accumulated Minority Interest5.686.145.605.00-
Total Equity952.45715.69101.7368.65-
Total Liabilities & Stockholders Equity6,458.116,120.873,512.742,461.89-
Book Value Per Share6.054.573.902.58-
Tangible Book Value Per Share5.614.141.250.09-
Full-Time Employees47,45545,68032,433--
Price to Book Ratio6.423.493.41--
Return on Assets3.051.163.78--
Return on Equity23.1313.84141.29--
Return on Invested Capital4.391.394.018.33-
Quick Ratio1.070.961.581.06-
Current Ratio1.070.961.581.06-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income277.61191.4655.34112.88150.5047.95
Depreciation73.6655.6640.8125.6322.317.15
Other Funds (Non Cash)153.98102.12157.4629.7716.02-0.97
Funds from Operations465.29331.51209.12158.36186.9161.96
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital114.4072.71158.22-94.66-94.29-4.36
Cash from Operating Activities579.69404.22367.3463.7092.6157.60
Capital Expenditures-131.96-105.41-66.47-45.78-22.86-124.09
Net Assets From Acquisitions-439.88-143.75-283.34-127.02-55.37-79.68
Sale of Fixed Assets and Businesses0.750.752.001.343.260.00
Purchase or Sale of Investments-80.31-15.62-94.37-0.732.90-14.84
Purchase of Investments-105.74-21.21-123.77-2.600.00-15.71
Sale Or Maturity of Investments25.435.5929.391.862.900.88
Other Uses-25.000.000.000.000.000.00
Other Sources19.620.000.000.000.000.00
Cash from Investing Activities-656.78-264.02-442.18-172.20-72.08-218.60
Cash Dividends Paid0.000.00-33.72-80.39-60.28-53.80
Change in Capital Stock4.250.00509.440.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock4.250.00509.440.000.000.00
Proceedsfrom Stock Options4.250.00509.440.000.000.00
Issuance or Reduction of Debt, Net-111.11-60.22-325.15209.4069.38235.84
Change in Long Term Debt-153.11-60.22-325.15209.4069.38235.84
Issuance of Long Term Debt299.000.00748.301,267.02242.43622.40
Reduction of Long Term Debt-452.11-60.22-1,073.45-1,057.62-173.05-386.55
Net Financing Active Other Cash Flow-46.91-8.77-33.600.000.000.00
Other Financing Activities Uses-46.91-8.77-33.600.000.000.00
Cash from Financing Activities-153.77-68.99116.97129.009.10182.05
Net Change in Cash-230.8671.2142.1420.5029.6421.05
Free Cash Flow447.73298.82300.8817.9169.75-66.48
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Price to Free Cash Flow15.2120.137.61---
Deferred Taxes & Investment Tax Credit--17.73-44.48-9.92-1.927.83

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments128.19176.91273.71232.05359.06297.64
Short Term Receivables750.10723.91733.22702.09694.71689.77
Inventories0.000.000.000.000.000.00
Other Current Assets68.4461.5361.17135.5972.9889.81
Total Current Assets946.74962.351,068.111,069.741,126.751,077.22
Net Property, Plant & Equipment4,421.374,260.184,216.074,169.274,134.274,067.30
Total Investments and Advances203.27185.68155.40105.60104.72102.56
Intangible Assets151.1268.0668.0668.0668.0667.06
Deferred Tax Assets---938.04--
Other Assets195.69180.05155.88107.40193.09188.02
Total Assets5,918.185,656.325,663.526,458.115,626.895,502.17
Short Term Debt Incl. Current Port. of LT Debt209.96192.97192.27186.46318.01432.24
Accounts Payable177.27160.88180.66192.23205.48172.02
Other Current Liabilities795.07701.21700.59622.73674.13562.96
Total Current Liabilities1,182.301,055.061,073.521,001.431,197.621,167.23
Long Term Debt3,231.573,211.953,314.243,411.623,335.993,276.30
Provision for Risks Charges243.58237.77208.95192.56177.48207.63
Deferred Tax Liabilities---874.08--
Other Liabilities42.0236.1324.6225.9838.8938.33
Total Liabilities4,699.474,540.924,621.335,505.664,749.984,689.50
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,214.261,110.401,037.17946.77871.32806.84
Total Shareholders Equity1,214.261,110.401,037.17946.77871.32806.84
Accumulated Minority Interest4.465.005.025.685.595.83
Total Equity1,218.711,115.401,042.19952.45876.92812.67
Total Liabilities & Stockholders Equity5,918.185,656.325,663.526,458.115,626.895,502.17
Book Value Per Share7.657.016.606.055.565.15
Tangible Book Value Per Share6.706.586.175.615.134.72
Full-Time Employees---47,455--
Price to Book Ratio6.426.465.316.90-3.44
Return on Assets4.814.824.373.053.332.81
Return on Equity26.6228.0827.2823.1322.0819.18
Return on Invested Capital1.371.771.851.371.251.25
Quick Ratio0.800.910.991.070.940.92
Current Ratio0.800.910.991.070.940.92

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income60.8176.3580.6759.7852.3350.97
Depreciation20.0820.1218.0815.3814.4013.18
Other Funds (Non Cash)58.9235.6931.9127.4624.6625.66
Funds from Operations122.26108.40118.20116.4376.8992.35
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital88.9827.11118.14-119.82127.91-39.78
Cash from Operating Activities211.24135.51236.34-3.39204.8052.57
Capital Expenditures-32.50-26.53-21.83-51.11-18.01-18.57
Net Assets From Acquisitions-185.52-104.28-86.92-63.16-80.35-0.24
Sale of Fixed Assets and Businesses0.000.000.000.750.000.00
Purchase or Sale of Investments-32.13-24.93-18.61-4.631.30-13.59
Purchase of Investments-36.25-43.39-20.05-6.05-0.05-15.11
Sale Or Maturity of Investments4.1118.461.441.421.351.52
Other Uses-25.000.000.000.000.000.00
Other Sources19.620.000.000.000.000.00
Cash from Investing Activities-255.53-155.74-127.36-118.15-97.06-32.41
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock4.250.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock4.250.000.000.000.000.00
Proceedsfrom Stock Options4.250.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.60-47.60-56.44-5.47-45.73-4.96
Change in Long Term Debt-1.60-47.60-56.44-47.47-3.73-4.96
Issuance of Long Term Debt237.0017.0045.000.000.000.00
Reduction of Long Term Debt-238.60-64.60-101.44-47.47-3.73-4.96
Net Financing Active Other Cash Flow-7.07-28.97-10.870.00-0.60-8.18
Other Financing Activities Uses-7.07-28.97-10.870.00-0.60-8.18
Cash from Financing Activities-4.42-76.57-67.31-5.47-46.32-13.13
Net Change in Cash-48.72-96.8041.66-127.0061.417.04
Free Cash Flow178.74108.98214.51-54.50186.7934.00
Price to Free Cash Flow15.2115.1513.6720.125.755.35

Revenue breakdown

United States2024: 4.09B 2025: 5.29B
Consolidation, Policy2024: -3.08M 2025: -1.05M
Reportable2024: 4.09B 2025: 5.29B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-309.41%4.3M45.6M798.04K
2026-10-159.53%4.3M45.5M794.35K
2026-09-309.11%4.1M45.4M822.53K
2026-09-158.24%3.7M45.4M858.18K
2026-08-317.40%3.3M45.0M880.49K
2026-08-148.03%3.6M44.6M916.37K
2026-07-318.54%3.8M44.8M922.76K
2026-07-1510.12%4.5M44.7M926.42K
2026-06-309.72%4.5M46.6M878.83K
2026-06-159.53%4.4M46.4M840.96K
2026-05-299.58%4.4M45.6M826.41K
2026-05-1510.11%4.3M42.4M894.28K
2026-04-3011.34%4.8M42.1M878.90K
2026-04-1510.57%4.4M41.8M905.89K
2026-03-3110.20%4.3M41.7M1.01M
2026-03-138.79%3.7M41.7M1.05M
2026-02-279.40%3.9M41.7M1.16M
2026-02-139.67%4.0M41.6M1.72M
2026-01-309.24%3.8M41.6M1.67M
2026-01-1510.46%4.3M41.6M1.58M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call22.5026.3029.7026.195.1552.000.000.992-0.0240.002
call25.0023.8026.6019.074.1061.000.000.991-0.0240.002
call30.0018.8021.700.003.3030.000.000.969-0.0620.005
call35.0014.0016.6013.502.48415.000.000.952-0.0690.008
call40.008.8011.508.951.76625.000.000.933-0.0630.010
call45.004.006.504.501.1441,0001.000.890-0.0530.015
call50.000.652.901.550.9213450.000.533-0.1610.031
call55.000.051.400.501.0111,5010.000.303-0.1570.027
call60.000.000.150.050.73231.004.000.063-0.0400.010
call65.000.001.150.000.9740.000.000.050-0.0450.008
put22.500.001.150.002.2870.000.00-0.008-0.0210.002
put25.000.000.050.052.41721.000.00-0.025-0.0590.004
put30.000.000.200.201.84034.000.00-0.032-0.0560.006
put35.000.000.400.101.4854170.00-0.048-0.0650.008
put40.000.000.950.101.0202950.00-0.067-0.0580.010
put45.000.051.050.190.58320368.00-0.110-0.0480.015
put50.000.752.702.050.88511.000.00-0.467-0.1550.031
put55.004.106.604.701.1171.000.00-0.697-0.1510.027
put60.007.9011.200.001.3750.000.00-0.937-0.0340.010
put65.0013.6016.200.001.7090.000.00-0.950-0.0370.008

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-29144Filing for proposed sale of securities under Rule 144.SEC
2026-10-28144Filing for proposed sale of securities under Rule 144.SEC
2026-10-28144Filing for proposed sale of securities under Rule 144.SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-16144Filing for proposed sale of securities under Rule 144.SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-253Initial statement of beneficial ownership of securities2026-09-21SEC
2026-09-218-KCurrent report2026-09-18SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110021.64M6
2026-100020.35M20
2026-090020.80M12
2026-080019.03M7
2026-070011.53M11
2026-060019.48M6
2026-05003.02M2
2026-040000
2026-03001.25M1
2026-020000
2026-010000
2025-120000
2025-11500.00K14.77M1

Institutional holders

Manager% owned
COHEN & STEERS, INC.5.27%
FMR LLC3.83%
BlackRock, Inc.2.63%
Crewe Advisors LLC2.09%
AMERICAN CENTURY COMPANIES INC1.96%
AMERIPRISE FINANCIAL INC1.26%
VANGUARD PORTFOLIO MANAGEMENT LLC1.25%
VANGUARD CAPITAL MANAGEMENT LLC1.16%
DIMENSIONAL FUND ADVISORS LP0.97%
Alyeska Investment Group, L.P.0.97%

Funds

Fund% owned
Cohen & Steers Real Estate Securities Fund1.68%
Fidelity Value Fund1.12%
Cohen & Steers Institutional Realty Shares0.82%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.79%
Avantis U.S. Small Cap Value ETF0.79%
Cohen & Steers Realty Shares0.77%
iShares Russell 2000 ETF0.77%
Fidelity Mid Cap Value Fund0.66%
Columbia Small Cap Growth Fund0.64%
VANGUARD SMALL-CAP INDEX FUND0.57%

OakChart. PACS. Cached 15 minutes.